Tag: Heart Failure
Sacubitril-Valsartan Does Not Cut Risk for Death, Heart Failure After MI
Sacubitril-valsartan not linked to reduced incidence of death from cardiovascular causes or incident heart failure versus ramipril
AHA: Use of Cardiac Rehab Low in Adults With Heart Failure
Rate of enrollment increased after Medicare expansion in 2014, but absolute enrollment rate in cardiac rehabilitation for HF patients still low
AHA: Sacubitril/Valsartan No More Beneficial for Chronic Advanced CHF
No benefit seen versus valsartan for reducing NT-proBNP levels for patients with chronic advanced heart failure and reduced ejection fraction
Cases of Takotsubo Syndrome Up in Middle-Aged, Older Women
Majority of cases (88.3 percent) seen in women, especially those aged 50 years or older; incidence higher in middle-aged men than younger men
SGLT2 Inhibitors May Cut Risk for Heart Failure Hospitalization
SGLT2 inhibitors, compared with GLP-1 RAs, linked to lower risk for heart failure hospitalization in patients with T2DM, with or without CVD
Early Rhythm Control Key in A-Fib and Heart Failure
Reduction seen in composite primary outcomes of CV death, stroke, hospitalization for worsening of heart failure or ACS
~40 Percent of Incident Heart Failure Diagnoses Occur in Acute Care
46 percent of those diagnosed in acute care had potential heart failure symptoms in previous six months
Methamphetamine-Linked Heart Failure Up in California
Increase of 585 percent seen in methamphetamine-associated cardiomyopathy/heart failure hospitalizations from 2008 to 2018
Heart Failure Linked to Increased Incidence of Cancer
Increased rates of cancer seen among women and men and for cancer at multiple sites, including lip, oral cavity, pharynx, respiratory organs
Statin Use May Cut Cancer Risk in Heart Failure Patients
Reduced risk for incident cancer and cancer-related mortality in patients with heart failure appears to depend on duration of statin use
